CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
is intended to assess the ability of AZD3427 to reduce pulmonary vascular resistance (PVR) after 24 weeks of treatment in participants with heart...
Phase 2
Milano, Italy and 63 other locations
This study is testing a potential new medicine, NNC6019-0001, for people who have a heart disease due to TTR amyloidosis.The study ...
Phase 2
Pavia, PV, Italy and 30 other locations
This study will evaluate the safety of the Cardiovalve Transfemoral Mitral Valve System with its associated procedure, and observe the device perform...
Milano, Italy and 10 other locations
Evaluation of TAVR using the NAVITOR valve in a Global Investigation.
Milan, Italy and 37 other locations
The purpose of the study is to evaluate the safety and effectiveness of the PULSTA Transcatheter Pulmonary Valve (TPV) System for the treatment of co...
Milan, San Donato Milanese, Italy and 10 other locations
The researchers are doing this study to look whether the type 2 diabetes medicine, semaglutide, has a positive effect on heart disease...
Phase 3
Milano, MI, Italy and 467 other locations
This study will test a medicine, NNC6019-0001, for people who have a heart disease due to TTR amyloidosis. It will look at how safe ...
Phase 2
Pavia, PV, Italy and 22 other locations
The purpose of this study is to establish the safety and effectiveness of pulsed field ablation as a first-line ablation treatment for subjects with...
Milano, MI, Italy and 49 other locations
2.5) device during high-risk PCI in patients with reduced left-sided heart function will result in an improvement in symptoms, heart...
Rozzano, Lombardy, Italy and 122 other locations
reduction of cardiovascular death (generally meaning death due to disease of the heart or blood vessels) and total Heart F...
Phase 3
Milano, Lombardia, Italy and 663 other locations
Clinical trials
Research sites
Resources
Legal